The PBM middleman’s primary job – MAKE MONEY!

NY State’s Self-Congratulatory BS Report on Opioid ‘Progress’

NY State’s Self-Congratulatory BS Report on Opioid ‘Progress’ https://www.acsh.org/news/2024/06/28/ny-states-self-congratulatory-bs-report-opioid-progress-48835 Let’s have a round of zero applause for the New York State Department of Health for its June 24th publication to physicians, misnamed “Data to Action Opioid Prescribing in New York State.” In a mastery of the self-evident, the authors reached this lame conclusion: if New […]

I asked perplexity.ai what would be the clinical reasons for a pharmacist to refuse to fill a prescription without contacting the prescriber

            This is a graphic representing the fictitious clinical facts that are starting to hit the fan Pharmacists play a critical role in ensuring the safe and effective use of medications. There are several clinical and regulatory reasons why a pharmacist might refuse to fill a prescription without first contacting […]

I asked perplexity.ai about the DEA statutory authority under CSA

This is a graphic representing the fictitious clinical facts that are starting to hit the fan Does the DEA have any statutory authority to establish medical standard of care and best practices under the controlled substance act? The Drug Enforcement Administration (DEA) does not have statutory authority to establish medical standards of care and best […]

I asked perplexity.ai about fixed opioid doses below FDA limits

            This is a graphic representing the fictitious clinical facts that are starting to hit the fan Is there any clinical justification to establish fixed opioid doses to treat chronic pain less than the FDA dosing guidelines Based on the available information, there is generally no clinical justification to establish […]

I ask perplexity.ai about the clinical studies supporting the MME system

Here is a published MME calculator https://globalrph.com/medcalcs/morphine-equivalent-dose-med-opioid-conversions/   This is the infamous MME system that those “so-called experts” based their 2016 CDC opioid dosing guidelines and what many bureaucracies – like the DEA & VA – seemed to have codified those guidelines as a standard of care and best practices as well as maybe 30+ states […]

I asked perplexity.ai about Benzodiazepine Equivalent calculations

Here is a published BME calculator  https://globalrph.com/medcalcs/benzodiazepine-converter-dosage-conversions/   Narxcare creates what they call an LME (Lorazepam Milligram Equivalent) value and includes it in their Narxcare PDM reports on pts that authorized healthcare professional can pull up reports on pts.             This is a graphic representing the fictitious clinical facts that are […]

I asked perplexity.ai about SCOTUS overturning of the Chevron’s Doctrine and the DEA

How will the end of Chevron deference impact the DEA rules and regulations and enforcement of existing interpretations of the Control Substance Act that the DEA has made since its inception in 1973, which are now probably illegal? The Supreme Court’s decision to overturn Chevron’s deference will likely have significant implications for the Drug Enforcement […]

CMS Incentivizes Payor Health Disparity Performance

CMS Incentivizes Payor Health Disparity Performance https://www.specialtypharmacycontinuum.com/Policy/Article/06-24/CMS-Incentivizes-Payor-Health-Disparity-Performance/74138 Medicare Advantage and other health plans are starting to pay more attention to medication adherence, social determinants or drivers of health (SDOH), and where they can intervene in health disparities—not only because it’s the right thing to do but because it will soon affect their bottom line, speakers […]

Supreme Court guts agency power – including DEA ..in seismic Chevron ruling

Supreme Court guts agency power in seismic Chevron ruling https://www.axios.com/2024/06/28/supreme-court-chevron-doctrine-ruling The Supreme Court on Friday curtailed the executive branch’s ability to interpret laws it’s charged with implementing, giving the judiciary more say in what federal agencies can do. Why it matters: The landmark 6-3 ruling along ideological lines overturns the court’s 40-year-old “Chevron deference” doctrine. […]